Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-02-15 12:57 Tx date 2023-02-01 |
$MPH
Medicure Inc. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,750
+75,000 vol $1.25 each |
95,000 | |
Filed 2022-06-03 12:57 Tx date 2022-05-30 |
$MPH
Medicure Inc. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+20,000 vol $1.20 each |
20,000 | |
Filed 2022-06-03 12:55 Tx date 2022-05-30 |
$MPH
Medicure Inc. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-04-01 10:02 Tx date 2021-04-01 |
$WAVE
WAVERLEY PHARMA INC. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$986.00
+6,800 vol $0.145 each |
28,800 | |
Filed 2020-09-21 09:56 Tx date 2020-09-21 |
$WAVE
WAVERLEY PHARMA INC. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,860
+12,000 vol $0.155 each |
22,000 | |
Filed 2020-09-14 12:27 Tx date 2020-09-11 |
$WAVE
WAVERLEY PHARMA INC. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+10,000 vol $0.16 each |
10,000 | |
Filed 2020-09-14 12:23 Tx date 2020-01-08 |
$WAVE
WAVERLEY PHARMA INC. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-02-04 17:30 Tx date 2020-02-01 |
$WAVE
WAVERLEY PHARMA INC. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,500
+75,000 vol $0.10 each |
75,000 | |
Filed 2020-02-04 17:29 Tx date 2020-01-08 |
$WAVE
WAVERLEY PHARMA INC. |
Uddin, Haaris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|